FRANK PRATT: Open Payments
NPI 1760564173 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,319 in 52 payments from 9 companies in 2025. Trend: 2023 $952 · 2024 $1,398 · 2025 $1,319
Food & beverage: $1,319
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $347 |
| Otsuka America Pharmaceutical, Inc. | 7 | $234 |
| Vanda Pharmaceuticals Inc. | 13 | $190 |
| ABBVIE INC. | 6 | $178 |
| Tris Pharma Inc | 7 | $164 |
| E.R. Squibb & Sons, L.L.C. | 1 | $112 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: REXULTI, Auvelity, FANAPT, VRAYLAR, Dyanavel XR, Sunosi, COBENFY, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
